163
Participants
Start Date
October 31, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Dapagliflozin
Tablets, Oral, once daily, up to 12 weeks
Placebo
Tablets, Oral, 0 mg, once daily, up to 12 weeks
Suny Upstate Medical University, Syracuse
Model Clinical Research Llc, Baltimore
Mountain Diabetes And Endocrine Center, Asheville
Endocrine Research Solutions, Inc., Roswell
Jacksonville Center For Clinical Research, Jacksonville
Your Diabetes Endocrine Nutrition Group, Mentor
Indiana University, Indianapolis
University Of Michigan, Ann Arbor
Advanced Healthcare S.C., Milwaukee
St. Louis Center For Clinical Research, St Louis
Nea Clinic, Jonesboro
Research Institute Of Dallas, P.A., Dallas
Diabetes And Glandular Disease Research Associates, P.A., San Antonio
Valley Research, Fresno
Bernstein, Richard, Greenbrae
Rainier Clinical Research Center, Renton
Local Institution, Winnipeg
Local Institution, Bathurst
Local Institution, Gatineau
Local Institution, Laval
Local Institution, Longueuil
Local Institution, Pointe-Claire
Local Institution, Sherbrooke
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY